Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04124874
Other study ID # 1072.6120.200.2019
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date October 15, 2019
Est. completion date December 1, 2020

Study information

Verified date March 2020
Source Jagiellonian University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The first large population-based study to evaluate lower urinary tract symptoms and their impact on quality of life in night workers.


Description:

The first large population-based study to evaluate lower urinary tract symptoms (LUTS) and their impact on quality of life in night workers. The study objective is to assess the prevalence and bother of LUTS in the population of night workers.

This study will be conducted as a questionnaire survey with assessment of LUTS using a standardized protocol based on definitions by the International Continence Society (ICS). The International Prostate Symptom Score (IPSS), the Overactive Bladder— Validated 8-question Screener (OAB-V8), the Patient Health Questionnaire-9 (PHQ-9), the Athen Insomnia Scale, the Work Productivity and Activity Impairment Questionnaire (WPAI), the 12-Item Short Form Health Survey (SF-12) questionnaires will be included. Participants will be also asked to rate how often they experienced individual LUTS and the degree of associated bother.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 10000
Est. completion date December 1, 2020
Est. primary completion date December 31, 2019
Accepts healthy volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

Night workers defined as any workers, who, during night time, work at least three hours of their daily working time as a normal course or who work at night at least 1/4 of their working time during the accounting period (definition by the Polish Labour Code).

Exclusion Criteria:

Non night workers Urinary tract infection in the past 4 weeks

Study Design


Related Conditions & MeSH terms


Intervention

Other:
There will be no intervention
There will be no intervention

Locations

Country Name City State
Poland Department of Urology Jagiellonian University Krakow

Sponsors (2)

Lead Sponsor Collaborator
Jagiellonian University Piotr Chlosta

Country where clinical trial is conducted

Poland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of LUTS The prevalence of LUTS will be assessed using definitions of the International Continence Society (descriptive statistics). Through study completion, an average of 3 months
Primary Symptom bother of LUTS The degree of associated bother will be assessed using Likert scale (Likert scale: not at all [score 0], a little bit [score 1], somewhat [score 2], quite a bit [score 3], a great deal [score 4], or a very great deal [score 5]). Through study completion, an average of 3 months
Secondary Prevalence of specific lower urinary tract symptoms The prevalence of specific lower urinary tract symptoms will be assessed using a standardised protocol based on the definitions provided by the International Continence Society (i.e. storage symptoms, voiding symptoms and post-micturition symptoms). Through study completion, an average of 3 months
Secondary Symptom bother of specific lower urinary tract symptoms The degree of associated bother of specific lower urinary tract symptoms will be assessed using Likert scale (Likert scale: not at all [score 0], a little bit [score 1], somewhat [score 2], quite a bit [score 3], a great deal [score 4], or a very great deal [score 5]). Through study completion, an average of 3 months
Secondary Prevalence of OAB The prevalence of OAB will be assessed with the Overactive Bladder—Validated 8-question Screener (OAB- V8) questionnaire. Through study completion, an average of 3 months
Secondary Prevalence of depressive symptoms The prevalence of depressive symptoms will be assessed with the PHQ-9 (Patient Health Questionnaire-9). Through study completion, an average of 3 months
Secondary Sleep quality The sleep quality will be assessed with the Athen Insomnia Scale questionnaire. Through study completion, an average of 3 months
Secondary Work productivity The work productivity will be assessed with the Work Productivity and Activity Impairment Questionnaire (WPAI). Through study completion, an average of 3 months
Secondary General quality of life The general quality of life will be assessed with the 12-Item Short Form Health Survey (SF-12). Through study completion, an average of 3 months